Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CHUK | O15111 | 1/20 | 0.34 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6356983 | 0.79 | CHUK (0.36) | CSNK2A1ALDH1A1CHUKNUDT1DHFR | |
| SCHEMBL2953678 | 0.79 | ADORA3 (0.38) | CSNK2A1ADORA3PARP1ALDH1A1L3MBTL1 | |
| SCHEMBL3158626 | 0.79 | CHUK (0.36) | CHUKDHFRDPP4 | |
| SCHEMBL12592351 | 0.79 | CSNK2A1 (0.38) | CSNK2A1ADORA3HTTPARP1KDM4E | |
| SCHEMBL22224331 | 0.79 | PDK2 (0.41) | CSNK2A1ADORA3HTTPARP1KDM4E | |
| Hydrochloric Acid SCHEMBL31329224 | 0.78 | CSNK2A1 (0.37) | CSNK2A1ADORA3HTTPARP1 | |
| SCHEMBL8216344 | 0.76 | ADORA3 (0.35) | CSNK2A1ADORA3PARP1ALDH1A1L3MBTL1 | |
| SCHEMBL6363420 | 0.76 | CHUK (0.32) | L3MBTL1CHUKDHFRHSP90AA1HSP90AB1 | |
| SCHEMBL16513125 | 0.75 | GAA (0.33) | ADORA3PARP1ALDH1A1KDM4E | |
| SCHEMBL19633362 | 0.72 | CDK1 (0.37) | CSNK2A1ADORA3HTTPARP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100531718-C | Slow-released injection containing methotrexate synergist | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2009-08-26 | — | — | CN | disclosed |
| CN-100500214-C | Slow released anticancer injection | JINAN SHUIHUA MEDICINE SCI TEC (CN) | 2009-06-17 | — | — | CN | disclosed |
| CN-101390827-A | Sustained-release injection containing methotrexate synergist | JINAN SHUAIHUA MEDICINE TECHNO (CN) | 2009-03-25 | — | — | CN | disclosed |
| CN-100431605-C | Anticarcinogen composition | LANJIN BIOLOG ENGINEERING CO L (CN) | 2008-11-12 | — | — | CN | disclosed |
| CN-101292954-A | Anti-cancer medicament sustained-release injection | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| CN-100402091-C | Anticarcinogen composition | SHANDONG LANJIN BIOLOG ENGINEE (CN) | 2008-07-16 | — | — | CN | disclosed |
| CN-101214220-A | Sustained-release injection containing amethopterin synergist | JINAN SHUAIHUA MEDICAL TECHNOL (CN) | 2008-07-09 | — | — | CN | disclosed |
| CN-100350975-C | Anticarcinogen composition | LANJIN BIOLOG ENGINEERING CO L (CN) | 2007-11-28 | — | — | CN | disclosed |
| CN-100350974-C | Anticarcinogen composition | LANJIN BIOLOG ENGINEERING CO L (CN) | 2007-11-28 | — | — | CN | disclosed |
| CN-101045059-A | Anticarcinogen composition carried with both nitrosourea type medicine and guanine analog | SHUAIHUA MEDICAL SCIENCE & TEC (CN) | 2007-10-03 | — | — | CN | disclosed |
| EP-0775142-B1 | SUBSTITUTED O6 -BENZYLGUANINES | US HEALTH (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6303604-B1 | USED AS ANTINEOPLASTIC ALKYLATING AGENT WHICH CAUSES CYTOTOXIC LESIONS AT THE O.SUP.6-POSITION OF QUANINE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-10-16 | — | — | US | disclosed |
| EP-1142893-A1 | Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6172070-B1 | IN POLYOXYETHYLENE GLYCOL CARRIER | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-01-09 | — | — | US | disclosed |
| US-5958932-A | ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-09-28 | — | — | US | disclosed |
| US-5916894-A | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-06-29 | — | — | US | disclosed |
| US-5753668-A | Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0775142-A1 | SUBSTITUTED O6 -BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5525606-A | CHEMOTHERAPEUTIC ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1996004281-A1 | SUBSTITUTED O6-BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-15 | — | — | WO | disclosed |